Investigators examined whether there is a connection between diabetes and increased risk for knee osteoarthritis.
Data show that the elderly are underrepresented in randomized clinical trials for rheumatoid arthritis and osteoarthritis.
Investigators examined the effect of an interdisciplinary, combined intervention in patients with hand osteoarthritis.
Patellar mobilization therapy plus exercise has the potential to reduce pain and improve function and quality of life for patients with knee OA.
Higher fibrosis scores were associated with lower radiographic disease severity over time in patients with knee osteoarthritis.
Knee pain predicted accelerated cartilage volume loss and increased risk for incident radiographic osteoarthritis.
Mechanistic pain profiling may help predict response to treatment for knee osteoarthritis with nonsteroidal anti-inflammatory drugs plus paracetamol.
The FDA has granted Fast Track designation for GLPG1972/S201086 for the treatment of osteoarthritis.
Four pain susceptibility phenotypes were identified in patients who had or were at risk for knee osteoarthritis, as well as risk factors for the development of persistent knee pain.
Researchers examined the effect of physical activity on cartilage thickness loss in knee osteoarthritis.
Researchers compared patient-physician discordance in global assessment in patients with osteoarthritis vs patients with rheumatoid arthritis seen in routine care.
Data show that low-dose radiation therapy does not lead to a substantial reduction in symptoms in patients with knee OA compared with sham therapy.
About 1 in 3 adults with prediabetes has arthritis, and half of those with both conditions are physically inactive and/or obese.
Exercise therapy does not increase the concentration of molecular biomarkers related to cartilage turnover and inflammation.
Researchers developed two models to estimate an individual's risk for primary THR and TKR.
Childhood maltreatment was associated with adulthood arthritis, particularly among those who experienced severe or frequent abuse.
Researchers evaluated measurement properties of self-report physical activity instruments for patients with osteoarthritis.
Weight loss in patients who are overweight or obese may improve symptoms through pathologic mechanisms in addition to reduction of joint burden.
Researchers examined the longitudinal relationship between bone mineral density and the incidence and progression of knee, hip, and hand osteoarthritis.
The use of gentamicin-impregnated beads and/or sponges should be discouraged in early acute periprosthetic joint infection as their use is associated with high failure rates.
Among patients undergoing TKA, aspirin alone may provide protection against postoperative VTE that is similar to that of other anticoagulants.
The presence of 3 common rheumatoid arthritis-associated antibodies were not associated with erosive disease in patients with hand osteoarthritis.
For individuals with knee OA, replacing time not walking with walking at moderate-to-vigorous intensity is associated with reduced risk for TKA over 5 years.
Yusuf Yazici, MD, discusses results from a trial evaluating a small molecule inhibitor of the Wnt pathway for the treatment of knee osteoarthritis.
Data from the PRECISION trial were used to develop and validate a clinical risk score for NSAID toxicity in OA and RA.
Patients generally experienced pain relief over 5 years regardless of whether they received physical therapy or arthroscopic partial menisectomy.
Metabolic syndrome, and specifically the component of abdominal obesity, may be associated with pain intensity and number of painful sites in adults with radiographic knee osteoarthritis.
David T. Felson, MD, MPH, and Jos Runhaar, PhD, reflect on important population-based osteoarthritis prevention strategies and knowledge gaps that still exist in this field.
A population-based, cohort study was conducted to identify knee pain in a group of older adults.
Investigators sought to determine if change in knee effusion volume from baseline to 1 year was predictive of cartilage volume loss and osteoarthritis progression in individuals at risk for osteoarthritis of the knee.
Rheumatology Advisor Articles
- One-Session Intervention for Hand OA Improved Grip Strength, Patient Satisfaction
- Exercise, TNFi Provide Differential Benefits for Cardiovascular Health in Rheumatoid Arthritis
- Improving RA Diagnosis With Use of Anti-ACPAs
- Anti-Drug Antibody Incidence Risk in RA Increases Over Time With Adalimumab, Infliximab
- MBDA Scores Reflect Response to Rituximab Treatment in Rheumatoid Arthritis
- Circadian Rhythm in Rheumatoid Arthritis: Using Chronotherapy to Improve Outcomes
- Inflammatory Arthritis and the Gut Microbiome: Do Microbes Hold the Key to New Treatments?
- Examining Insurance Complications in the Shared Decision Making Process for Rheumatoid Arthritis
- Filgotinib Safe, Effective for Treatment of Active Ankylosing Spondylitis
- FDA Fast Track Designation Granted for Investigational Osteoarthritis Treatment
- Ultrasonography in Gout: Potential Applications for Diagnosis and Patient Monitoring
- AMA Code of Medical Ethics Guides Physicians in Fighting Harmful Online Health Information
- Immunogenicity of Golimumab Validated Using Novel Anti-Drug Antibody Detection Assay
- Poor Vitamin K Status Linked to Low BMD, Increased Fracture Risk in ESRD
- Most Insured Patients Not Using Online Portals